PictorLabs, a Los Angeles, CA-based software company transforming histopathology with AI-powered virtual staining, has raised $30 million in Series B funding.
Investors
The round was led by Insight Partners with continued support from M Ventures.
Insight Partners is a global software investor specializing in high-growth technology, software, and internet startups and ScaleUps driving transformative change in their industries. As of December 31, 2023, the firm manages over $80 billion in assets. Insight Partners has invested in more than 800 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has additional offices in London, Tel Aviv, and the Bay Area.
PictorLabs Use of Funds
The new funds will enable PictorLabs to further advance its technology, expand its market reach, and accelerate the adoption of AI-driven virtual staining in clinical and research settings.
About PictorLabs
PictorLabs is a digital pathology company spun off from the UCLA Colleges of Engineering and Medicine, PictorLabs is redefining histological staining—a critical process for diagnosing and researching cancer, infectious diseases, and other pathological conditions. PictorLabs provides an AI-powered virtual staining platform designed to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes.
Funding Details
Company: PictorLabs, Inc.
Raised: $30.0M
Round: Series B
Funding Date: September 2024
Lead Investor: Insight Partners
Additional Investor: M Ventures
Company Website: https://www.pictorlabs.ai/
Software Category: AI Virtual Staining
Source: https://www.prnewswire.com/news-releases/pictorlabs-raises-30-million-in-series-b-funding-to-accelerate-ai-powered-virtual-staining-technology-302251226.html